IP Library Granted Patent US 10,519,472
Granted Patent B2
US 10,519,472 · App. 14/655,610 · Granted Dec 31, 2019

Recombinant host cell for biosynthetic production

Inventors: Odile Ramaen (Ablis, FR); Vincent Sauveplane (Elancourt, FR); Rudy Pandjaitan (Maisons Alfort, FR)
Assignee: RHODIA OPERATIONS
C12P7/24C12N1/16C12N9/0028C12N9/0042C12N9/0073C12N9/1007C12N9/88C12N9/93C12N15/52C12Y105/01036C12Y106/02004C12Y114/13002C12Y114/13007C12Y114/13011C12Y201/01068C12Y301/01073C12Y402/01C12Y402/01017C12Y403/01023C12Y403/01024C12Y403/01025C12Y602/01012
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,519,472
App. No.
14/655,610
Granted
Dec 31, 2019
Kind
B2
Abstract

A cell may include heterologous polynucleotides encoding a multienzyme complex involved in the metabolic pathway of phenylpropanoids and biosynthesis of a vanilloid or a hydroxybenzaldehyde precursor thereof, which multienzyme complex comprises enzymes for the biosynthesis of coumaric acid and a crotonase.

Claims (44)

1. A yeast cell comprising heterologous polynucleotides encoding a multienzyme complex, wherein the multienzyme complex is involved in the metabolic pathway of phenylpropanoids and biosynthesis of a vanilloid or a hydroxybenzaldehyde precursor thereof, and wherein the multienzyme complex comprises: a) a crotonase, b) a CoA ligase, c) a 3-monooxygenase; and d) a methyltransferase; wherein a) is enoyl-CoA hydratase (ECH), b) is 4-coumarate-CoA ligase (4CL), c) is hydroxybenzoic acid hydroxylase (HBH), or phenolhydroxylase (PheA) and flavinreductase (FLARED); and d) is O-methyltransferase.

2. The yeast cell according to claim 1 , which multienzyme complex comprises

a) phenylalanine ammonia lyase (PAL), cinnamic acid hydroxylase (C4H), cytochrome P450 reductase (CPR), 4 coumarate-CoA ligase (4CL), enoyl-CoA hydratase (ECH), hydroxybenzoic acid hydroxylase (HBH), or phenolhydroxylase (PheA) and flavinreductase (FLARED), and a O-methyltransferase;

b) tyrosine ammonia lyase (TAL), 4-coumarate-CoA ligase (4CL), enoyl-CoA hydratase (ECH), hydroxybenzoic acid hydroxylase (HBH), or phenolhydroxylase (PheA) and flavinreductase (FLARED), and a O-methyltransferase; or

c) phenylalanine/tyrosine ammonia lyase (PAL TAL), cinnamic acid hydroxylase (C4H), cytochrome P450 reductase (CPR), 4-coumarate-CoA ligase (4CL), enoyl-CoA hydratase (ECH), hydroxybenzoic acid hydroxylase (HBH), or phenolhydroxylase (PheA) and flavinreductase (FLARED), and a O-methyltransferase.

3. The yeast cell according to claim 1 , wherein enoyl-CoA hydratase (ECH) is any of

a) an ECH responsible for the chain reduction reaction on p-coumaroylCoA and/or feruloylCoA;

b) an ECH converting p-coumaroylCoA to 4-hydroxybenzaldehyde; or

c) an ECH converting feruloylCoA to vanillin.

4. The yeast cell according to claim 1 , which further comprises

a) a heterologous polynucleotide encoding a carboxyreductase (CAR), optionally together with a polynucleotide encoding a phosphopantetheinyl transferase (PPTase); and/or

b) a heterologous polynucleotide encoding an alcohol oxidase.

5. The yeast cell according to claim 1 , wherein the yeast cell is of a genera selected from the group consisting of Saccharomyces, Pichia, Hansenula, Schizosaccharomyces, Kluyveromyces, Yarrowia and Candida.

6. The yeast cell according to claim 1 , wherein the yeast cell is a DNA repair deficient cell or a production cell comprising a cluster of polynucleotides assembled in a DNA repair deficient cell.

7. The yeast cell according to claim 1 , wherein polynucleotides encoding a series of enzymes are expressed from a single polycistronic operon, or wherein polynucleotides encoding a series of enzymes are expressed from separate promoters.

8. The yeast cell according to claim 1 , wherein the polynucleotides are stably integrated into the cell genome.

9. The yeast cell according to claim 1 , wherein the polynucleotides originate from at least two different species.

10. The yeast cell according to claim 1 , wherein at least one of the enzymes is a chimeric enzyme.

11. The yeast cell according to claim 10 , wherein the chimeric enzyme is

a) encoded by a nucleotide sequence that is composed of fragments of different polynucleotides, which fragments are assembled to a chimeric nucleotide sequence; and/or

b) encoded by a nucleotide sequence that is obtained by insertion, deletion and/or substitution of one or more nucleotides in a parent polynucleotide.

12. The yeast cell according to claim 1 , wherein the vanilloid is selected from the group consisting of vanillin, vanillic acid, ethyl-vanillin, vanillyl alcohol and vanillin-glycoside.

13. The yeast cell according to claim 1 , wherein the hydroxybenzaldehyde precursor is selected from the group consisting of protocatechuic aldehyde, protocatechuic acid, protocatechuic alcohol, 4-hydroxybenzaldehyde, 4-hydroxybenzoic acid, 4-hydroxybenzyl alcohol, cinnamic acid, coumaric acid, caffeic acid and ferulic acid.

14. A method of engineering a yeast cell according to claim 1 by introducing heterologous polynucleotides encoding a multienzyme complex involved in the metabolic pathway of phenylpropanoids and biosynthesis of a vanilloid or a hydroxybenzaldehyde precursor thereof, into the cell genome, comprising

a) providing the polynucleotides encoding i) a crotonase, ii) a CoA ligase, ii) a-3-monooxygenase; and iv) a methyltransferase, wherein i) is enoyl-CoA hydratase (ECH), ii) is 4-coumarate-CoA ligase (4CL), iii) is hydroxybenzoic acid hydroxylase (HBH), or phenolhydroxylase (PheA) and flavinreductase (FLARED); and iv) is a O-methyltransferase;

b) assembling the polynucleotides into a cluster and integrating said cluster into the cell genome; and

c) optionally engineering a yeast production cell, wherein said cluster is stably integrated in the production cell genome.

15. A method, comprising:

producing a vanilloid or a hydroxybenzaldehyde precursor thereof by heterologous biosynthesis from a yeast cell according to claim 1 .

16. A method of heterologous biosynthesis of a vanilloid or a hydroxybenzaldehyde precursor thereof, by conversion of a precursor compound employing a multienzyme complex, comprising

a) providing a yeast cell according to claim 1 ;

b) cultivating said cell in a cell culture in the presence of the precursor compound;

c) accumulating a vanilloid or a hydroxybenzaldehyde precursor thereof;

and

d) separating said vanilloid or hydroxybenzaldehyde precursor thereof from the cell culture medium.

17. The method of claim 16 , wherein said product is a

i. vanilloid selected from the group consisting of vanillin, vanillic acid, ethyl-vanillin, vanillyl alcohol and vanillin-glycoside; or

ii. a hydroxybenzaldehyde precursor selected from the group consisting of protocatechuic aldehyde, protocatechuic acid, protocatechuic alcohol, 4-hydroxybenzaldehyde, 4-hydroxybenzoic acid, 4-hydroxybenzyl alcohol, cinnamic acid, coumaric acid, caffeic acid and ferulic acid.

18. The yeast cell of claim 1 , wherein the enzymes for the biosynthesis of coumaric acid are selected from the group consisting of: a phenylalanine ammonia lyase (PAL), a tyrosine ammonia lyase (TAL), and a phenylalanine/tyrosine ammonia lyase (PAL/TAL).

19. The yeast cell of claim 18 , wherein the multienzyme complex further comprises one or more enzymes to convert an aromatic amino acid into coumaric acid.

20. The yeast cell of claim 1 , wherein the crotonase is suitable for performing a chain reduction reaction on feruloylCoA or coumaroylCoA.

21. The yeast cell of claim 18 , wherein the crotonase is suitable for performing a chain reduction reaction on feruloylCoA or coumaroylCoA.

22. The yeast cell of claim 19 , wherein the crotonase is suitable for performing a chain reduction reaction on feruloylCoA or coumaroylCoA.

23. The yeast cell of claim 5 , wherein the cell is Saccharomyces cerevisiae.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2024
From: RHODIA OPERATIONS
To: SPECIALTY OPERATIONS FRANCE
Reel/Frame 066374/0642 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2023
From: RHODIA OPERATIONS
To: SPECIALTY OPERATIONS FRANCE
Reel/Frame 065488/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2019
From: EVIAGENICS
To: RHODIA OPERATIONS
Reel/Frame 050935/0046 →
Priority Claims (2)
EP 12199502 · Dec 27, 2012 · regional
EP 13156021 · Feb 20, 2013 · regional
Continuity (1)
Related Publication 20150322465A1 · Nov 12, 2015